Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis-Reference-Cited by-同舟云学术

Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis

Published:2023-08-08 Issue:1 Volume:83 Page:1-9
ISSN:1559-0100
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Karimi Farzaneh^ORCID,Dinarvand Negar^ORCID,Sabaghan Mohammad^ORCID,Azadbakht Omid^ORCID,Ataee Shima^ORCID,Kharazinejad Ebrahim^ORCID,Moazamfard Mostafa

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-023-03477-6.pdf

Reference74 articles.

1. T. Chowdhury, Diabetes and cancer. QJM Int. J. Med. 103(12), 905–915 (2010).

2. I.L. Romero et al. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. Obstet. Gynecol. 119(1), 61–67 (2012). https://doi.org/10.1097/AOG.0b013e3182393ab3. ppJan

3. K. Müssig, H.-U. Häring, Insulin signal transduction in normal cells and its role in carcinogenesis. Exp. Clin. Endocrinol. Diabetes 118(06), 356–359 (2010).

4. M. Pollak, Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 8(12), 915–928 (2008).

5. D.M. Lamkin et al. Glucose as a prognostic factor in ovarian carcinoma. Cancer 115(5), 1021–1027 (2009).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ratio of PKM1/PKM2 is the key factor affecting the glucose metabolism and biological function of colorectal cancer cells;Translational Cancer Research;2024-07

2. Drug Repositioning for Ovarian Cancer Treatment: An Update;Anti-Cancer Agents in Medicinal Chemistry;2024-05

3. Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer;BMC Genomics;2024-01-02